Literature DB >> 30796436

Synthetic Cannabinoids JWH-122 and THJ-2201 Disrupt Endocannabinoid-Regulated Mitochondrial Function and Activate Apoptotic Pathways as a Primary Mechanism of In Vitro Nephrotoxicity at In Vivo Relevant Concentrations.

João P Silva1, Ana Margarida Araújo1, Paula Guedes de Pinho1, Helena Carmo1, Félix Carvalho1.   

Abstract

The widespread recreational use of synthetic cannabinoids (SCBs) represents a major public health issue, as reports of intoxications and deaths following SCB use rapidly mount up. Specifically, a direct link between SCB use and acute kidney injury (AKI) has been established, although the pathophysiologic mechanisms remain undefined. Here we assessed the in vitro nephrotoxicity of 3 commonly detected and structurally distinct SCBs-AB-FUBINACA, JWH-122, and THJ-2201-in human proximal tubule cells (HK-2), to ascertain potential similarities and/or differences regarding their nephrotoxicity signatures. We showed that 2 of the 3 SCBs tested, namely JWH-122 and THJ-2201, at in vivo relevant concentrations (1 nM-1 μM), triggered apoptotic cell death pathways, mainly through a shared mechanism involving the deregulation of mitochondrial function (ie, with mitochondrial membrane hyperpolarization and increased intracellular ATP levels), as the primary molecular signature of nephrotoxicity mechanism. Noteworthy, no SCB affected cell viability (MTT reduction, lactate dehydrogenase release, Neutral Red inclusion). Use of the cannabinoid receptor (CBR) antagonists SR141716A and SR144528, as well as HEK293T cells, which do not express CBRs, confirmed the involvement of these receptors in SCB-mediated mitochondrial membrane hyperpolarization but not on other events, suggesting an off-target action regulating SCB-induced kidney cell death. Our results further strengthen the relevance of the endocannabinoid system in maintaining mitochondrial function in kidney cells, as we demonstrate that HK-2 incubation with CBR antagonists or inhibitors of endocannabinoid biosynthesis (ie, methyl arachydonyl fluorophosphonate, tetrahydrolipstatin) alone produced deleterious effects similar to those now reported for SCBs. Overall, SCB-induced nephrotoxicity seems to be mainly regulated at the mitochondrial level, but the specific mechanisms involved require further clarification.
© The Author(s) 2019. Published by Oxford University Press on behalf of the Society of Toxicology. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  acute kidney injury; apoptosis; cannabinoid receptors; endocannabinoid system; mitochondrial membrane potential; new psychoactive substances

Mesh:

Substances:

Year:  2019        PMID: 30796436     DOI: 10.1093/toxsci/kfz050

Source DB:  PubMed          Journal:  Toxicol Sci        ISSN: 1096-0929            Impact factor:   4.849


  7 in total

1.  Pharmacological affinity fingerprints derived from bioactivity data for the identification of designer drugs.

Authors:  Kedan He
Journal:  J Cheminform       Date:  2022-06-07       Impact factor: 8.489

2.  Genotoxic Properties of Synthetic Cannabinoids on TK6 Human Cells by Flow Cytometry.

Authors:  Monia Lenzi; Veronica Cocchi; Luca Cavazza; Sabrine Bilel; Patrizia Hrelia; Matteo Marti
Journal:  Int J Mol Sci       Date:  2020-02-09       Impact factor: 5.923

Review 3.  Stress-mediated generation of deleterious ROS in healthy individuals - role of cytochrome c oxidase.

Authors:  Rabia Ramzan; Sebastian Vogt; Bernhard Kadenbach
Journal:  J Mol Med (Berl)       Date:  2020-04-20       Impact factor: 4.599

4.  Determination of the Synthetic Cannabinoids JWH-122, JWH-210, UR-144 in Oral Fluid of Consumers by GC-MS and Quantification of Parent Compounds and Metabolites by UHPLC-MS/MS.

Authors:  Nunzia La Maida; Manuela Pellegrini; Esther Papaseit; Clara Pérez-Mañá; Lourdes Poyatos; Mireia Ventura; Liliana Galindo; Francesco Paolo Busardò; Simona Pichini; Magí Farré; Emilia Marchei
Journal:  Int J Mol Sci       Date:  2020-12-10       Impact factor: 5.923

5.  In-depth comparison of the metabolic and pharmacokinetic behaviour of the structurally related synthetic cannabinoids AMB-FUBINACA and AMB-CHMICA in rats.

Authors:  David Fabregat-Safont; María Mata-Pesquera; Manuela Barneo-Muñoz; Ferran Martinez-Garcia; Marie Mardal; Anders B Davidsen; Juan V Sancho; Félix Hernández; María Ibáñez
Journal:  Commun Biol       Date:  2022-02-24

Review 6.  Designer drugs: mechanism of action and adverse effects.

Authors:  Dino Luethi; Matthias E Liechti
Journal:  Arch Toxicol       Date:  2020-04-06       Impact factor: 5.153

7.  The Synthetic Cannabinoids THJ-2201 and 5F-PB22 Enhance In Vitro CB1 Receptor-Mediated Neuronal Differentiation at Biologically Relevant Concentrations.

Authors:  João Alexandre; Rui Malheiro; Diana Dias da Silva; Helena Carmo; Félix Carvalho; João Pedro Silva
Journal:  Int J Mol Sci       Date:  2020-08-30       Impact factor: 5.923

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.